Featured Video Play Icon

New laboratory and production site for Oncology medicines

Did you know that Tiefenbacher Group is in the final phase of constructing a new, state-of-the-art laboratory and production site for highly potent drugs against cancer and other diseases?

The new complex is located at Tiefenbacher Laboratories in Hyderabad, India, and covers a total area of approximately 4,000 m². It provides laboratories with the latest equipment and full safety measures, as well as an additional production block with special technologies in a GMP-compliant environment.  Tiefenbacher Pharmaceuticals (FDF business unit of Tiefenbacher Group) has already more than 20 leading highly potent drugs in its launch pipeline which are planned to be developed and produced in the new facilities.

These investments in infrastructure and technology reflect the company’s commitment to continuously improving healthcare and making high-quality medicines more affordable, more available and better than before. The new site is expected to be fully operational still this year.

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com

Tiefenbacher Pharmaceuticals, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).

For more information about our finished dosage forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com


Tiefenbacher Group celebrating US Independence Day

Tiefenbacher Group celebrating US Independence Day

Today is one of the most important public holidays in the United States of America, celebrating its freedom.

At the 4th July 1776, by the adoption of the Declaration of Independence, it declared its independence from Great Britain. 

On this day, US-Americans all over the world come together to celebrate the spirit of American freedom and unity. Generally in form of parades, vibrant fireworks, barbecues and of cause coming together as a family.  

As a 100% family-owned healthcare company we greatly appreciate the diversity of our colleagues. Therefore we are looking forward to celebrating their local traditions together. We have also been to numerous fairs and events this year to meet US customers and partners in person to talk about how we make pharmaceuticals more affordable, more available, and better than before for people in America!  

That is why on this day, we join you in embracing the freedom that makes innovation possible and paves the way for breakthrough healthcare that can improve the lives of millions of Americans.

Happy Independence Day! 

Tiefenbacher Group celebrating US Independence Day

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at info@tiefenbacher.com or visit us on www.tiefenbachergroup.com

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes genericvalue added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).
For more information about our finished dosage (FDF) forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com


Tiefenbacher Group Bike to work days 2024

Tiefenbacher Group "Bike to work days"

This month, some of our valued Tiefenbacher Group colleagues took part in the "Bike to Work Days". A total of 786 journeys to work were made by bike and an incredible 15,000 kilometers were cycled!

Lease a Bike topped up the donation amount to €1 for every kilometer cycled, raising a total of €15,000 for the SOS Children’s Village Düsseldorf. SOS Children’s Villages is a non-governmental, independent organization that is active in 137 countries. It is committed to meeting the needs of children, including providing counselling and care, but mainly by running so-called children’s villages to give children a safe home.

Tiefenbacher’s employee contribution is 379.6 kilometers cycled, thank you very much! Your commitment not only contributes to your own health and the environment, but also supports children and young people.

As a healthcare company dedicated to improving people’s lives, this great initiative fits perfectly with our company ideology. Tiefenbacher Group has a strong belief in the Duty of Care we have for our employees. We take care of their health and wellbeing as much as possible – and we aim to be an attractive employer by offering everyone additional benefits and well-being.

That’s why, since 2022, all employees at the Hamburg headquarter have been able to choose from a wide range of company bicycles that they can lease to get around in a climate-friendly way. We have plenty of bicycle parking spaces in our underground car park – including numerous electric charging stations for electric vehicles.

A great way for everyone to keep fit and healthy – in line with our strategy of doing business sustainably!

Tiefenbacher Group Bike to work days 2024

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at info@tiefenbacher.com or visit us on www.tiefenbachergroup.com

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes genericvalue added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).
For more information about our finished dosage (FDF) forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com


Tiefenbacher Group Luncheon in Hyderabad

Tiefenbacher Group Luncheon in Hyderabad

It is a tradition at Tiefenbacher Group that our new employees can take part in an open table talk and luncheon with the leadership team, this time in Hyderabad.

This involves an open discussion about their first impressions of their new workplace and what they think about the management style, as well as an information session to find out more about Tiefenbacher’s strategy.

Furthermore, it’s an opportunity to talk about their impressions of the company and to get answers to any questions they may have. After the table talk, all participants are invited to luncheon, where they can discuss other topics in greater depth and get to know each other better.

We are delighted that our tradition has also found favour at our location in India. Last week, the leadership team of AET Tiefenbacher Laboratories and all employees who joined the company between January and June had their first luncheon and table talk in Hyderabad. Thanks to all participants for the successful event and the positive feedback. We are already looking forward to the next occasion in Hamburg.

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at info@tiefenbacher.com or visit us on www.tiefenbachergroup.com

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes genericvalue added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).
For more information about our finished dosage (FDF) forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com


Tiefenbacher Group football cup

Tiefenbacher Group Football Cup 2024

Just in time for the start of the UEFA Euro 2024 kick off in Germany, the Tiefenbacher Group in Hamburg organized its annual football tournament.

This year, more than 200 people (employees and their families) turned up to join the Tiefenbacher Group Football Cup. They spend a wonderful sunny day playing football together, cheering on the team and then rounding off the day with food and drinks.

In a high-scoring competition, the Team Polar Bears ultimately prevailed out of the 5 teams in a dramatic final against Team Lime Legends after a shootout. Congratulations Jens Müller, Paul-Kester Schulz, Birte Wrogemann, Daniel Weizel, Katharina Wolff, Sebastian Kirschberger, Bastian Höger, Hasan Abualruz for winning this year’s Tiefenbacher Cup!!!!

A big thank you to the organizers Ulrike Klingenberg & Florian Herb for the great work and of course a special thanks to all colleagues who helped to organize the Cup this year! We are already looking forward to next year’s tournament.

Tiefenbacher Group football cup

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes genericvalue added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).
For more information about our finished dosage (FDF) forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at info@tiefenbacher.com or visit us on www.tiefenbachergroup.com


Tiefenbacher Group draws attention to blood donation

Tiefenbacher Group draws attention to blood donation

On today's World Blood Donor Day, Tiefenbacher Group would like to actively support the Red Cross blood donation services and draw attention to blood donation and its importance for society with the #MissingType campaign.

Anyone can suddenly find themselves in need of a blood transfusion. Some accident victims are dependent on 50 or more units of blood to survive. Many medical interventions – such as operations or cancer treatments – are only possible today if a sufficient amount of human blood is available. In Germany alone, around 15,000 blood donations and approx. 5,000 plasma donations are needed every day.

It has not yet been possible to replace blood with another liquid or substance. Blood is therefore unique and blood donations are absolutely essential for patient care. Patients are therefore dependent on the constant commitment of blood donors.

We are delighted about the many employees who have volunteered to donate their blood and thus give other people the opportunity to continue living. Thank you for your support!

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at info@tiefenbacher.com or visit us on www.tiefenbachergroup.com

TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes genericvalue added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).
For more information about our finished dosage (FDF) forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com


Tiefenbacher Group Buprenorphin launch Australia

Tiefenbacher New Market Launch: Buprenorphine in Australia

Tiefenbacher Pharmaceuticals successfully prepared the launch of the analgesic Buprenorphine as Transdermal Patch in Australia.

We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. A key point here is that this applies to everyone, regardless of their nationality or income. That´s why we are thrilled to share that we have successfully prepared the launch of the generic version of the analgesic Buprenorphine as Transdermal Patch in Australia.

Affordable Medicines (fka Generics) are therapeutically equivalent to their branded counterparts with a lower price due to losing patent protection. The low cost of generic medications promotes patient affordability and contributes to lower per capita healthcare spending.

Buprenorphine belongs to a class of drugs known as opioid analgesics. Buprenorphine patches are used to help relieve severe and persistent pain (such as due to arthritis or chronic back pain). Our cooperation partner marketed the Transdermal Patches in the strengths 5mcg, 10mcg, 15mcg, and 20mcg. This product has already been launched in several international markets before.

The successful launch of this affordable medicine is a testament to the hard work and dedication of our team. The positive impact for the Australian healthcare system is one thing we are particularly excited about. We look already forward to further market entries of our high-quality medicines.

Please click the highligthed words if you would like to know more about our product portfolio.

TIEFENBACHER PHARMACEUTICALS  is a part of Tiefenbacher Group. We develop and commercialize generic, value added, and innovative pharmaceuticals as well as medical devices and e-health-solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.  

For more information about our finished dosage forms (FDF) including highly potent drugs and e-healthcare solutions, please contact us at  info@tiefenbacher.com or visit us on  www.tiefenbacher-pharmaceuticals.com

Tiefenbacher Group Buprenorphin launch Australia

NEW MARKET LAUNCH: Bilastine as Oral Dispersible Tablet (ODT)

Tiefenbacher Pharmaceuticals successfully prepared the launch of the antihistamine Bilastine as Oral Dispersible Tablet (ODT) medicine in Germany

The allergy season is undoubtedly in full swing. We at Tiefenbacher Group are therefore thrilled to announce that we have successfully prepared the launch of our latest anti-allergy medicine, Bilastine Oral Dispersible Tablet (ODT) in Germany – available from now on in German pharmacies without a prescription. We are particularly pleased to offer Bilastine (ODT) for the first time in 10mg strawberry flavoured tablets which we developed especially for children aged 6-11 years.

Patients who suffer from the following allergic symptoms: Hay fever, hives, urticaria and other allergic reactions are thus offered a more convenient and user-friendly way to control their allergy. The introduction of the oral dispersible tablet form is basically a response to the needs of patients – especially to those who are seeking a more flexible and also a discreet way to manage their allergies, particularly when on the go.

Bilastine Oral Dispersible Tablet (ODT) is designed to disintegrate quickly in the mouth without the need for water. This way, patients with difficulties swallowing tablets or without immediate access to water can use the device with ease.

The 10 mg tablets for children and the 20 mg tablets for adults have been developed in Tiefenbacher Group´s own laboratories. They will be marketed by our partner, a well-known international pharmaceutical company. With the market entry of Bilastine Oral Dispersible Tablet we enable patients in Germany a better access to an important medicine since, it is currently available in pharmacies without a prescription needed.

The successful launch of this antihistamine reflects our ongoing commitment to providing patients with high-quality, cost-effective medications. Undeniably it is a testament to the hard work and dedication of the team.

Finally, we are particularly excited about the positive impact this achievement will have. However we look forward to further market entries with high-quality medicines – with a patient-centred approach for better healthcare.

TIEFENBACHER PHARMACEUTICALS  is a part of Tiefenbacher Group. We develop and commercialize generic, value added, and innovative pharmaceuticals as well as medical devices and e-health-solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.  

For more information about our finished dosage forms (FDF) including highly potent drugs and e-healthcare solutions, please contact us at  info@tiefenbacher.com or visit us on  www.tiefenbacher-pharmaceuticals.com


Featured Video Play Icon

Tiefenbacher Group celebrates The International Day of Families

Today we celebrate The International Day of Families!

We would like to use the International Day of Families to talk about our Tiefenbacher Group family. Since 1963 Tiefenbacher Group is a 100% family-owned healthcare company. Until today the company is owned by the direct descendants of our founding father Alfred E. Tiefenbacher. To this day, his unique entrepreneurial spirit is our driving force in pioneering healthcare by making medicines more affordable, more globally available, and better than before.

The greatest strength of Tiefenbacher Group is our employees, our family. We believe that their curiosity, their passion for healthcare, and their diversity are the foundation of our success.

Our employees´ performance achievements and their inventiveness are the daily basis for our entrepreneurial accomplishments to make a sustainable difference in patient care.

We put our passion for improving people’s lives into practice. Therefore we want every employee to enjoy coming to work every day. Working at Tiefenbacher Group is characterized by mutual appreciation, fairness, and transparency. In our day-to-day work we certainly focus on challenging the status quo. Furthermore we are highly optimistic, take initiative, and strive for speed and pragmatism making things happen. A career with us means working for a company that values you and your well-being.

Therefore, we endeavor to provide every member of our Tiefenbacher Group family with the working environment they need to thrive – because we believe that those who are passionate about what they do are the ones who succeed.

Happy International Day of Families!

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com

Tiefenbacher Pharmaceuticals, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).

For more information about our finished dosage forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com


Featured Video Play Icon

TIEFENBACHER API + INGREDIENTS offers custom synthesis of intermediates & APIs

Synthesis of Active Pharmaceutical Ingredients (API) : From route scouting to lab scale development to commercial supply 

Did you know that Tiefenbacher API + Ingredients not only offers a broad range of high-quality APIs, but also offers custom synthesis of intermediates & APIs? 

The synthesis of APIs is a critical step in the development and manufacturing of high-quality pharmaceuticals. It is a multi-step process involving numerous chemical transformations. Particularly purification, separation and operations on a range of raw materials with different physical and chemical properties. 

We at TIEFENBACHER API + INGREDIENTS surely make it right the first time, from grams to tons. Generally a structured and methodical approach enables us to identify your individual requirements and implement them precisely. Our significantly strong network of 200+ manufacturing partners and our sophisticated market intelligence allow us to choose the best fit. We work closely with you and the selected CDMO during all the planning and execution phases. Thus, to assure we meet your and the product’s requirements. 

Whatever challenges you face throughout the sourcing process or the synthesis of APIs for your pharmaceuticals. Regardless of the size or complexity of your project, you can be sure that together we can develop a customised solution for your specific requirements.

TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com

Tiefenbacher Pharmaceuticals, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).

For more information about our finished dosage forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com